Sinonasal Acinic Cell Carcinoma: A Review of the National Cancer Database
- PMID: 35702005
- DOI: 10.1177/19458924221107206
Sinonasal Acinic Cell Carcinoma: A Review of the National Cancer Database
Abstract
Background: Acinic cell carcinoma (ACC) is a salivary gland malignancy that rarely can involve the sinonasal cavity. There are limited outcomes data available to guide management.
Objective: We sought to use the National Cancer Database (NCDB) to characterize treatment outcomes in sinonasal ACC.
Methods: A retrospective analysis of the NCDB from 2004 to 2016 for patients with ACC involving the sinonasal cavity was conducted. Demographic, treatment, and survival information were obtained. Unadjusted Kaplan-Meier estimates, log-rank tests, and a multivariable Cox proportional hazard model were used to assess overall survival (OS).
Results: A total of 28 patients were included in the analysis with an average age of 58.6 ± 15.5 years. Half the patients (n = 14, 50%) were male, mostly white (n = 23, 82.1%), and with private insurance (n = 16, 57.1%). The nasal cavity was the most common subsite (n = 18, 64.3%), followed by the maxillary sinus (n = 5, 17.9%). Most patient received surgery alone (n = 17, 60.7%), with the remaining patients undergoing surgery followed by radiation (n = 8, 28.6%), radiation alone (n = 1, 3.6%), and no treatment (n = 2, 7.1%). The 1-, 5-, and 10-year survival in this cohort was 100% (95% CI: 100%-100%), 84.3% (95% CI: 71.2%-99.7%), and 72.2% (95% CI: 55%-94.8%), respectively. On multivariate analysis, older age was associated with worse OS (hazard ratio (HR): 1.27; 95% CI: 1.11-1.46, P < .001). Disease of the sphenoid sinus correlated with worse survival (HR: 198, 95% CI: 10.4-3,739, P < .001) and large tumor size was associated with worse OS on log-rank test, but not on multivariate analysis.
Conclusion: Sinonasal ACC is a rare entity with relatively good long-term outcomes. Older age and primary disease of the sphenoid sinus are associated with worse outcomes. Most patients are treated with surgical resection. Future research is needed to assess the optimal timing and indications for radiation therapy.
Keywords: NCDB; National Cancer Database; acinar cell; acinic cell; cancer; outcomes; sinonasal; sinus; skull base; survival.
Similar articles
-
A National Cancer Database Analysis of Sinonasal Malignant Myoepithelial Carcinoma Outcomes.Am J Rhinol Allergy. 2023 Jan;37(1):7-12. doi: 10.1177/19458924221121419. Epub 2022 Aug 15. Am J Rhinol Allergy. 2023. PMID: 35971225
-
Sinonasal mucoepidermoid carcinoma: a review of the National Cancer Database.Int Forum Allergy Rhinol. 2019 Sep;9(9):1046-1053. doi: 10.1002/alr.22379. Epub 2019 Jul 17. Int Forum Allergy Rhinol. 2019. PMID: 31314958
-
Carcinosarcoma of the nasal cavity and paranasal sinuses: Review of the national cancer database.World J Otorhinolaryngol Head Neck Surg. 2022 Oct 27;9(2):115-122. doi: 10.1002/wjo2.82. eCollection 2023 Jun. World J Otorhinolaryngol Head Neck Surg. 2022. PMID: 37383334 Free PMC article.
-
Sinonasal acinic cell carcinoma: a clinicopathologic study of four cases.Head Neck. 2005 Jul;27(7):603-7. doi: 10.1002/hed.20186. Head Neck. 2005. PMID: 15900565 Review.
-
Sinonasal lymphoma: case series and review of the literature.Int Forum Allergy Rhinol. 2014 Aug;4(8):670-4. doi: 10.1002/alr.21337. Epub 2014 Apr 23. Int Forum Allergy Rhinol. 2014. PMID: 24760602 Review.
Cited by
-
Results of Primary Treatment and Salvage Treatment in the Management of Patients with Non-Squamous Cell Malignant Tumors of the Sinonasal Region: Single Institution Experience.J Clin Med. 2023 Mar 1;12(5):1953. doi: 10.3390/jcm12051953. J Clin Med. 2023. PMID: 36902738 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources